These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 18154475

  • 1. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D, Buadi FK, McClune B.
    Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
    [Abstract] [Full Text] [Related]

  • 2. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N, DePestel DD, Mackler ER, Collins CD, Welch K, Erba HP.
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [Abstract] [Full Text] [Related]

  • 3. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 4. Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
    den Hollander JG, van Arkel C, Rijnders BJ, Lugtenburg PJ, de Marie S, Levin MD.
    J Antimicrob Chemother; 2006 Jun; 57(6):1248-50. PubMed ID: 16556632
    [Abstract] [Full Text] [Related]

  • 5. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH.
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A.
    J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
    [Abstract] [Full Text] [Related]

  • 13. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    Supparatpinyo K, Schlamm HT.
    Am J Trop Med Hyg; 2007 Aug; 77(2):350-3. PubMed ID: 17690411
    [Abstract] [Full Text] [Related]

  • 14. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O.
    Clin Infect Dis; 2008 Jan 15; 46(2):201-11. PubMed ID: 18171251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 15; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 19. Voriconazole concentrations and outcome of invasive fungal infections.
    Miyakis S, van Hal SJ, Ray J, Marriott D.
    Clin Microbiol Infect; 2010 Jul 15; 16(7):927-33. PubMed ID: 19845698
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.